Diagnostic significance of obesity phenotype’s metabolic criteria in females and their connection with accompanying diseases and states


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The aim of present investigation was to study the role of different diagnostic criteria of phenotypes and their correlation with diseases and states associated with alimentary-constitutional obesity in females. Methods. There were examined 273 females with over weight and alimentary-constitutional obesity. Examination included anthropometry, measurement of blood pressure (BP), laboratory tests. All patients were separated on 4 groups depending on age and phenotype:1-st patients with normal sensitivity to insulin and without other characteristics of MS (30%); 2-nd - females with the resistance to insulin and without MS characteristics (15%); 3-d included patients with the insulin resistance and MS characteristics (37,8%); 4-th group - females with MS and normal sensitivity to insulin (17,2%). Results. Cardiovascular risks and phenotype of obesity are mostly determined by sensitivity to insulin and MS characteristics (triglycerides level, Cholesterol of high density and WC). Insuline resistance, already presented at young age, in 50% is accompanied by fat hepatitis, elevation of cholesterol total, Cholesterol of lipoproteines, leptine blood level and is a risk factor of development of MS on oldery. Metabolic syndrome, presented without insulin resistance, should be attributed to non-healthy obesity, because it increases cardio-vascular risk and in these patients fat hepatitis and hormonal and metabolic disbalances are confirmed more often.

Full Text

Restricted Access

About the authors

M. B Lyasnikova

Tver State Medical University of Healthcare Ministry of Russian Federation

Email: mashulyasnik@mail.ru
Candidate of Medical Sciences

N. A Belyakova

Tver State Medical University of Healthcare Ministry of Russian Federation

Email: mashulyasnik@mail.ru
Professor, MD

N. O Milaya

Tver State Medical University of Healthcare Ministry of Russian Federation

Email: mashulyasnik@mail.ru

I. G Tsvetkova

Tver State Medical University of Healthcare Ministry of Russian Federation

Email: mashulyasnik@mail.ru
Candidate of Medical Sciences

L. A Slezkina

Tver State Medical University of Healthcare Ministry of Russian Federation

Email: mashulyasnik@mail.ru
Candidate of Medical Sciences

A. V Lareva

Tver State Medical University of Healthcare Ministry of Russian Federation

Email: mashulyasnik@mail.ru
Candidate of Medical Sciences

References

  1. Крысанова В.С., Журавлева М.В., Сереброва С.Ю. Социальная и экономическая значимость избыточной массы тела и ожирения в Российской Федерации. Основные подходы к лечению ожирения. РМЖ. 2015; 23 (26): 1534-7
  2. Стародубова А.В., Стародубов В.И. Тенденции, возрастные и региональные особенности заболеваемости ожирением населения Российской Федерации в 1992-2012 гг. Профилактическая медицина. 2017; 6: 32-40. doi: 10.17116/profmed201720632-40
  3. Вербовой А.Ф., Шаронова Л.А., Пашенцева А.В. и др. Инсулинорезистентность и заболевания внутренних органов. Врач. 2017; 9: 17-22.
  4. Collins K.H., Herzog W., MacDonald G.Z. et al. Obesity, Metabolic Syndrome, and Musculoskeletal Disease: Common Inflammatory Pathways Suggest a Central Role for Loss of Muscle Integrity. Front Physiol. 2018; 9: 112. doi: 10.3389/fphys.2018.00112
  5. Meigs J.B., Wilson P.W., Fox C.S. et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006; 91 (8): 2906-12. doi: 10.1210/jc.2006-0594
  6. Thompson J., Regnault T. In Utero Origins of Adult Insulin Resistance and Vascular Dysfunction. Semin Reprod Med. 2011; 29 (03): 211-24. doi: 10.1055/s-0031-1275522
  7. Самородская И.В. Ожирение: надежность критериев оценки, соотношение вреда и пользы. Врач. 2014; 4: 5-8.
  8. Stefan N., Haring H.U. Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med. 2013; 19 (4): 394-5. doi: 10.1038/nm.3116
  9. Островская Е.В., Романцова Т.И., Герасимов А.Н. и др. Распространенность метаболически здорового ожирения по данным выборки Московского региона. Ожирение и метаболизм. 2017; 14 (4): 51-6. doi: 10.14341/OMET2017451-56
  10. Aguilar-Salinas C.A., Garcia E.G., Robles L. et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab. 2008; 93 (10): 4075-9. doi: 10.1210/jc.2007-2724
  11. Агафонова О.В., Гриценко Т.А., Богданова Ю.В. и др. Поликлиническая терапия: Учебник. Под ред. Д.И. Давыдкина, Ю.В. Щукина. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2020; 840 с. doi: 10.33029/9704-5545-6-PLT-2020-1-840
  12. Berezina A., Belyaeva O., Berkovich O. et al. Prevalence, Risk Factors, and GeneticTraits in Metabolically Healthy and Unhealthy Obese Individuals. BioMed Res Int. 2015; 2015: 1-9. doi: 10.1155/2015/548734
  13. Диагностика, лечение, профилактика ожирения и ассоциированных с ним заболеваний. Национальные клинические рекомендации. СПб, 2017 Режим доступа: https://mirvracha.ru/article/klinicheskie_rekomendatsii_po_ diagnostike_i_lecheniyu_ozhireniya
  14. Wildman R.P., Muntner P., Reynolds K. et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008; 168 (15): 1617-24. doi: 10.1097/01.ogx.0000338100.83483.58
  15. Суплотова Л.А., Сметанина С.А., Плотников Н.В. Клиникометаболические и молекулярно-генетические ассоциации у женщин репродуктивного возраста при инсулинорезистентности, ожирении и метаболическом синдроме. Медицинская наука и образование Урала. 2013; 2 (74): 84-7.
  16. Хамедова М.Ш., Серебрякова В.Н., Трубачева И.А. и др. Распространенность отдельных компонентов метаболического синдрома среди педагогов. Сибирский медицинский журнал. 2013; 3 (28): 77-81.
  17. Смирнова Е.Н., Шулькина С.Г. Содержание лептина, растворимых рецепторов лептина и индекса свободного лептина у больных с метаболическим синдромом. Ожирение и метаболизм. 2017; 14 (1): 30-4. doi: 10.14341/0MET2017130-34. URL: https://cyberleninka.ru/article/n/soderzhanie-leptina-rastvorimyh-retseptorov-leptina-i-indeksa-svobodnogo-leptina-u-bolnyh-s-metabolicheskim-sindromom
  18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285 (19): 2486-97. doi: 10.1001/jama.285.19.2486

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies